Key result
Administration of recombinant mouse IL-5 reduced infarct size and increased ejection fraction and angiogenesis in mice post-myocardial infarction by promoting eosinophil accumulation.
Why the study?
It remains unknown whether interleukin-5 plays a role in heart repair after myocardial infarction.
Does recombinant IL-5 improve cardiac function and reduce infarct size in a mouse model of myocardial infarction?
Does recombinant IL-5 improve cardiac function and reduce infarct size in a mouse model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
IL-5 facilitates recovery of cardiac dysfunction post-MI by promoting eosinophil accumulation and CD206+ macrophage polarization.
AIMS: Interleukin (IL)-5 mediates the development of eosinophils (EOS) that are essential for tissue post-injury repair. It remains unknown whether IL-5 plays a role in heart repair after myocardial infarction (MI). This study aims to test whether IL-5-induced EOS population promotes the healing and repair process post-MI and to reveal the underlying mechanisms. METHODS AND RESULTS: MI was induced by permanent ligation of the left anterior descending coronary artery in wild-type C57BL/6 mice. Western blot and real-time polymerase chain reaction revealed elevated expression of IL-5 in the heart at 5 days post-MI. Immunohistostaining indicated that IL-5 was secreted mainly from macrophages and CD127+ cells in the setting of experimental MI. External supply of recombinant mouse IL-5 (20 min, 1 day, and 2 days after MI surgery) reduced the infarct size and increased ejection fraction and angiogenesis in the border zone. A significant expansion of EOS was detected in both the peripheral blood and infarcted myocardium after IL-5 administration. Pharmacological depletion of EOS by TRFK5 pretreatment muted the beneficial effects of IL-5 in MI mice. Mechanistic studies demonstrated that IL-5 increased the accumulation of CD206+ macrophages in infarcted myocardium at 7 days post-MI. In vitro co-culture experiments showed that EOS shifted bone marrow-derived macrophage polarization towards the CD206+ phenotypes. This activity of EOS was abolished by IL-4 neutralizing antibody, but not IL-10 or IL-13 neutralization. Western blot analyses demonstrated that EOS promoted the macrophage downstream signal transducer and activator of transcription 6 (STAT6) phosphorylation. CONCLUSION: IL-5 facilitates the recovery of cardiac dysfunction post-MI by promoting EOS accumulation and subsequent CD206+ macrophage polarization via the IL-4/STAT6 axis.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2021) studied Myocardial infarction. Recombinant mouse IL-5 was evaluated on Infarct size, ejection fraction, and angiogenesis. Administration of recombinant mouse IL-5 reduced infarct size and increased ejection fraction and angiogenesis in mice post-myocardial infarction by promoting eosinophil accumulation.
Synapse has enriched 10 related papers. Consider them for comparative context: